Skip to main content

Table 3 Univariable cox regression analysis for possible predictors of all-cause mortality, cardiovascular events and cardiovascular mortality

From: Prognostic values of left ventricular mass index progression in incident peritoneal dialysis patients : a prospective cohort study

 

All-cause mortality

Cardiovascular events

Cardiovascular mortality

HR

95.0% CI

p

HR

95.0% CI

p

HR

95%CI

p

Age

1.054

1.032–1.076

 < 0.001

1.037

1.017–1.057

 < 0.001

1.036

1.006–1.066

0.017

Sex

0.792

0.445–1.412

0.430

0.546

0.300–0.914

0.048

0.657

0.268–1.612

0.359

History of diabetes

2.547

1.451–4.470

0.001

2.684

1.556–4.629

 < 0.001

2.650

1.142–6.151

0.023

BMI (kg/m2)

1.135

1.083–1.217

 < 0.001

1.119

1.032–1.214

0.006

1.069

0.945–1.209

0.287

MAP

0.998

0.967–1.030

0.904

1.021

0.991–1.052

0.181

1.022

0.976–1.071

0.353

Use of statins

1.263

0.553–2.882

0.579

1.639

0.875–3.069

0.123

1.978

0.773–5.509

0.155

Use of RAAS antagonists

0.577

0.317–1.049

0.072

0.575

0.323–1.024

0.060

0.389

0.143–1.055

0.064

Use of anti-hypertensive drugs

0.683

0.271–1.723

0.419

0.895

0.322–2.489

0.832

2.451

0.103–3.256

0.404

LVMI (g/m2)

1.010

1.001–1.020

0.027

1.017

1.008–1.025

 < 0.001

1.012

0.999–1.026

0.073

LVMI -progression

1.417

1.049–1.915

0.023

1.359

1.015–1.820

0.039

1.475

0.935–2.326

0.095

Hemoglobin (g/L)

0.990

0.970–1.010

0.319

0.996

0.977–1.016

0.717

1.005

0.974–1.038

0.735

Albumin (g/L)

0.954

0.890–1.023

0.187

1.011

0.940–1.088

0.761

1.046

0.938–1.165

0.418

CHO (mmol/L)

1.028

0.748–1.412

0.866

0.971

0.705–1.337

0.857

1.022

0.637–1.640

0.928

LDL (mmol/L)

1.239

0.820–1.874

0.309

1.187

0.790–1.783

0.408

1.243

0.676–2.286

0.484

TG (mmol/L)

0.883

0.659–1.182

0.403

0.977

0.759–1.257

0.856

0.531

0.273–1.036

0.063

HDL (mmol/L)

1.157

0.438–3.057

0.768

0.354

0.115–1.091

0.071

1.867

0.481–7.244

0.367

ApoA (g/L)

1.262

1.108–1.437

 < 0.001

1.127

1.103–1.463

0.001

1.315

1.140–1.517

 < 0.001

ApoB (g/L)

2.495

0.411–3.309

0.772

1.953

0.293–12.992

0.489

0.682

0.109–29.868

0.682

hsCRP (mg/L)

1.001

0.967–1.037

0.936

1.018

0.992–1.044

0.178

1.004

0.955–1.055

0.884

nPCR (g/kg/24 h)

0.040

0.006–0.256

0.001

0.107

0.017–0.653

0.016

0.222

0.016–3.123

0.265

Urinary output(L/24 h)

0.542

0.309–0.952

0.033

0.856

0.499–1.467

0.571

0.771

0.325–1.830

0.556

Total Ccr (L/week)

0.997

0.985–1.009

0.646

0.998

0.987–1.010

0.786

1.001

0.984–1.019

0.880

Residual renal Ccr (L/week)

0.997

0.986–1.008

0.575

0.998

0.987–1.008

0.650

0.999

0.989–1.009

0.872

Total Kt/V

1.075

0.931–1.241

0.326

1.081

0.931–1.254

0.305

1.148

0.997–1.323

0.055

Residual renal Kt/V

0.814

0.438–1.511

0.514

0.834

0.460–1.511

0.549

0.995

0.403–2.459

0.992

Proportion of 1.5%-glucose dialysate(%)

1.452

0.263–8.014

0.669

1.057

0.172–6.479

0.952

2.080

0.178–24.236

0.559

Volume of dialysate (per1000mL/24 h)

1.319

1.096–1.586

0.003

1.294

1.075–1.557

0.006

1.193

0.898–1.583

0.223